Related references
Note: Only part of the references are listed.Vancomycin dosing and therapeutic drug monitoring practices: guidelines versus real-life
Tatjana Van Der Heggen et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2021)
Therapeutic monitoring of vancomycin for serious -methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2020)
Maturational changes in vancomycin protein binding affect vancomycin dosing in neonates
Stephanie Leroux et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Continuous Versus Intermittent Vancomycin Infusions in Infants: A Randomized Controlled Trial
Amanda Gwee et al.
PEDIATRICS (2019)
Developing a paediatric drug formulary for the Netherlands
Tjitske M. van der Zanden et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2017)
Dosing antibiotics in neonates: review of the pharmacokinetic data
Nazario D. Rivera-Chaparro et al.
FUTURE MICROBIOLOGY (2017)
Vancomycin dosing and target attainment in children
David Hwang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2017)
Global shortage of neonatal and paediatric antibiotic trials: rapid review
Georgina Thompson et al.
BMJ OPEN (2017)
The Whole Price of Vancomycin: Toxicities, Troughs, and Time
Meghan N. Jeffres
DRUGS (2017)
Therapeutic drug monitoring in neonates
Steven Pauwels et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2016)
Therapeutic guidelines for prescribing antibiotics in neonates should be evidence-based: a French national survey
Stephanie Leroux et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2015)
High variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: implications for research and dissemination
Tuuli Metsvaht et al.
BMC PEDIATRICS (2015)
Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target
Jiraganya Bhongsatiern et al.
THERAPEUTIC DRUG MONITORING (2015)
Optimization of time to initial vancomycin target trough improves clinical outcomes
Anthony P. Cardile et al.
SPRINGERPLUS (2015)
Medication Use in the Neonatal Intensive Care Unit
Emily M. Hsieh et al.
AMERICAN JOURNAL OF PERINATOLOGY (2014)
Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring
Wei Zhao et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2013)
A survey of beta-lactam antibiotics and vancomycin dosing strategies in intensive care units and general wards in Belgian hospitals
F. M. Buyle et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2013)
Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units
S. Kadambari et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Vancomycin - Pharmacokinetics and administration regimens in neonates
M de Hoog et al.
CLINICAL PHARMACOKINETICS (2004)
Share Paper
